The CEO and General Manager of Afana Biotechnology is fully responsible for the overall operation and development of the company. Over 20 years of experience in multinational corporations, expert in strategic planning, capital and commercial management: previously served as the Chief Strategy Officer of Sinopharm, Chief Operating Officer of Royal Caribbean Group, etc., completing a $200 million financing for innovative pharmaceutical companies, listing on the Science and Technology Innovation Board, and a $1.5 billion+overseas authorization transaction; Leading two international brands to become the top brand and market share in related fields in China.